LRI Investments’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.5K Buy
349
+293
+523% +$15.1K ﹤0.01% 820
2026
Q1
$3.32K Buy
56
+9
+19% +$584 ﹤0.01% 1184
2025
Q4
$2.88K Sell
47
-21
-31% -$1.28K ﹤0.01% 1141
2025
Q3
$4.25K Hold
68
﹤0.01% 1077
2025
Q2
$5.45K Hold
68
﹤0.01% 1001
2025
Q1
$5.86K Hold
68
﹤0.01% 905
2024
Q4
$5.33K Hold
68
﹤0.01% 914
2024
Q3
$5.64K Hold
68
﹤0.01% 904
2024
Q2
$4.7K Buy
+68
New +$4.61K ﹤0.01% 912

Other funds holding PBH

LRI Investments's PBH Position: Q2 2026 in Review

LRI Investments increased its Prestige Consumer Healthcare (PBH) stake by 523% in Q2 2026, buying an estimated $15.1K and bringing the position to 349 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #820.

LRI Investments first reported a position in PBH in Q2 2024 and has held it in 9 quarters since. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • LRI Investments held 349 shares of Prestige Consumer Healthcare worth $16.5K as of Q2 2026.
  • LRI Investments bought 293 Prestige Consumer Healthcare shares in Q2 2026, an estimated $15.1K.
  • Prestige Consumer Healthcare made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #820 holding.
  • LRI Investments first reported a position in Prestige Consumer Healthcare in Q2 2024 and has held it in 9 quarters since.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.